This article reviews the development history of chimeric antigen receptor macrophage(CAR-M)therapy,discusses its application in malignant hematologic diseases,introduces related clinical trials,analyzes the advantages and challenges faced by CAR-M therapy in clinical application,and looks forward to its future use in the treatment of malignant hematologic diseases.
NETL
NSTL
万方数据
